Phase ii dose-selection, randomised, controlled trial of asi bi 690517 with and without empag-liflozin in chronic kidney disease: subgroup analysis by type 2 diabetes status

Francesca Tang; Peter Rossing; Sibylle Hauske; Lisa Cronin; Hiddo Lambers Heerspink; Juliane Meyerhoff; Shimoli Shah; Zhichao Sun; Dick De Zeeuw; Morag Nelson; Katherine Tuttle

doi:10.1111/nep.14362

Phase ii dose-selection, randomised, controlled trial of asi bi 690517 with and without empag-liflozin in chronic kidney disease: subgroup analysis by type 2 diabetes status

Francesca Tang, Peter Rossing, Sibylle Hauske, Lisa Cronin, Hiddo Lambers Heerspink, Juliane Meyerhoff, Shimoli Shah, Zhichao Sun, Dick De Zeeuw, Morag Nelson, Katherine Tuttle

Steno Diabetes Center Copenhagen

Originalsprog	Engelsk
Tidsskrift	Nephrology
Vol/bind	29
Udgave nummer	1
Sider (fra-til)	72-73
Antal sider	2
ISSN	1320-5358
DOI	https://doi.org/10.1111/nep.14362
Status	Udgivet - 1 aug. 2024
Begivenhed	59th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology - Adelaide, Australien Varighed: 31 aug. 2024 → 4 sep. 2024 Konferencens nummer: 59

Konference

Konference	59th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology
Nummer	59
Land/Område	Australien
By	Adelaide
Periode	31/08/2024 → 04/09/2024

Adgang til dokumentet

10.1111/nep.14362Licens: Ikke-specificeret

https://onlinelibrary.wiley.com/doi/10.1111/nep.14362

Citationsformater

Tang, F., Rossing, P., Hauske, S., Cronin, L., Heerspink, H. L., Meyerhoff, J., Shah, S., Sun, Z., De Zeeuw, D., Nelson, M., & Tuttle, K. (2024). Phase ii dose-selection, randomised, controlled trial of asi bi 690517 with and without empag-liflozin in chronic kidney disease: subgroup analysis by type 2 diabetes status. Nephrology, 29(1), 72-73. https://doi.org/10.1111/nep.14362

Phase ii dose-selection, randomised, controlled trial of asi bi 690517 with and without empag-liflozin in chronic kidney disease: subgroup analysis by type 2 diabetes status. / Tang, Francesca; Rossing, Peter; Hauske, Sibylle et al.
I: Nephrology, Bind 29, Nr. 1, 01.08.2024, s. 72-73.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Tang, F, Rossing, P, Hauske, S, Cronin, L, Heerspink, HL, Meyerhoff, J, Shah, S, Sun, Z, De Zeeuw, D, Nelson, M & Tuttle, K 2024, 'Phase ii dose-selection, randomised, controlled trial of asi bi 690517 with and without empag-liflozin in chronic kidney disease: subgroup analysis by type 2 diabetes status', Nephrology, bind 29, nr. 1, s. 72-73. https://doi.org/10.1111/nep.14362

@article{fd67904feda44f2993f0431bcf5013fa,

title = "Phase ii dose-selection, randomised, controlled trial of asi bi 690517 with and without empag-liflozin in chronic kidney disease: subgroup analysis by type 2 diabetes status",

author = "Francesca Tang and Peter Rossing and Sibylle Hauske and Lisa Cronin and Heerspink, {Hiddo Lambers} and Juliane Meyerhoff and Shimoli Shah and Zhichao Sun and {De Zeeuw}, Dick and Morag Nelson and Katherine Tuttle",

year = "2024",

month = aug,

day = "1",

doi = "10.1111/nep.14362",

language = "English",

volume = "29",

pages = "72--73",

journal = "Nephrology",

issn = "1320-5358",

publisher = "Wiley-Blackwell",

number = "1",

note = "59th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, ANZSN ; Conference date: 31-08-2024 Through 04-09-2024",

}

TY - ABST

T1 - Phase ii dose-selection, randomised, controlled trial of asi bi 690517 with and without empag-liflozin in chronic kidney disease: subgroup analysis by type 2 diabetes status

AU - Tang, Francesca

AU - Rossing, Peter

AU - Hauske, Sibylle

AU - Cronin, Lisa

AU - Heerspink, Hiddo Lambers

AU - Meyerhoff, Juliane

AU - Shah, Shimoli

AU - Sun, Zhichao

AU - De Zeeuw, Dick

AU - Nelson, Morag

AU - Tuttle, Katherine

N1 - Conference code: 59

PY - 2024/8/1

Y1 - 2024/8/1

U2 - 10.1111/nep.14362

DO - 10.1111/nep.14362

M3 - Conference abstract in journal

SN - 1320-5358

VL - 29

SP - 72

EP - 73

JO - Nephrology

JF - Nephrology

IS - 1

T2 - 59th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology

Y2 - 31 August 2024 through 4 September 2024

ER -